5 molecular monitoring protocols reducing 2026 recurrence rates
Post-surgical surveillance is undergoing a radical transformation in 2026 as hospitals adopt "molecular relapse" protocols. Instead of waiting for a CT scan to show a tumor's return, clinicians are now using ultra-sensitive liquid assays to detect minimal residual disease (MRD). This proactive approach is being bolstered by France oncology screening AI, which provides clinicians in Paris...
0 Comments 0 Shares 240 Views 0 Reviews